Standardizing case definitions for monitoring the safety of maternal vaccines globally: GAIA definitions, a review of progress to date

Int J Gynaecol Obstet. 2023 Jul;162(1):29-38. doi: 10.1002/ijgo.14843. Epub 2023 May 16.

Abstract

In 2014, the Global Alignment on Immunization safety Assessment in pregnancy consortium (GAIA) was formed, with the goal of developing a harmonized, globally-concerted approach to actively monitor the safety of vaccines in pregnancy. A total of 26 standardized definitions for the classification of adverse events have been developed. The aim of this review was to identify and describe studies undertaken to assess the performance of these definitions. A literature search was undertaken to identify published studies assessing the performance of the definitions, and reference lists were snowballed. Data were abstracted by two investigators and a narrative review of the results is presented. Four studies that have evaluated 13 GAIA case definitions (50%) were identified. Five case definitions have been assessed in high-income settings only. Recommendations have been made by the investigators to improve the performance of the definitions. These include ensuring consistency across definitions, removal of the potential for ambiguity or variations in interpretation and ensuring that higher-level criteria are acceptable at lower levels of confidence. Future research should prioritize the key case definitions that have not been assessed in low- and middle-income settings, as well as the 13 that have not undergone any validation.

Keywords: adverse events; maternal vaccination; neonatal infections; pharmacovigilance; pregnancy; vaccine safety.

Publication types

  • Review

MeSH terms

  • Family
  • Female
  • Humans
  • Immunization / adverse effects
  • Income
  • Pregnancy
  • Vaccination
  • Vaccines* / adverse effects

Substances

  • Vaccines